References
- S U. Food and Drug Administration. Information for consumers on using dietary supplement; 2017. Available from: https://www.fda.gov/Food/DietarySupplements/UsingDietarySupplements/default.htm. Accessed October 25, 2023.
- Nih.gov. Office of dietary supplements - dietary supplement health and education act of 1994. Available from: https://ods.od.nih.gov/About/DSHEA_Wording.aspx. Accessed March 12, 2022.
- Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug administration warnings. JAMA Network Open. 2018;1(6):e183337. doi:10.1001/jamanetworkopen.2018.3337
- Office of Regulatory Affairs. Health fraud product database. U.S. Food and Drug Administration. Available from: https://www.fda.gov/consumers/health-fraud-scams/health-fraud-product-database. Accessed October 25, 2023.
- Corona G, Mondaini N, Ungar A, Razzoli E, Rossi A, Fusco F. Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient. J Sex Med. 2011;8(12):3418–3432. doi:10.1111/j.1743-6109.2011.02473.x
- Kee CL, Ge X, Gilard V, Malet-Martino M, Low MY. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. J Pharm Biomed Anal. 2018;147:250–277. doi:10.1016/j.jpba.2017.07.031
- U. S. Food and Drug Administration. ‘Rhino 69 Extreme 50000’ Recalled due to presence of active ingredient ‘Tadalafil’; 2018. Available from: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/rhino-69-extreme-50000-recalled-due-presence-active-ingredient-tadalafil. Accessed October 25, 2023.
- Jiru M, Stranska-Zachariasova M, Dzuman Z, et al. Analysis of phosphodiesterase type 5 inhibitors as possible adulterants of botanical-based dietary supplements: extensive survey of preparations available at the Czech market. J Pharm Biomed Anal. 2019;164:713–724. doi:10.1016/j.jpba.2018.11.007
- Bujang NB, Chee CF, Heh CH, Rahman NA, Buckle MJC. Phosphodiesterase-5 inhibitors and their analogues as adulterants of herbal and food products: analysis of the Malaysian market, 2014-16. Food Addit Contam Part a Chem Anal Control Expo Risk Assess. 2017;34(7):1101–1109. doi:10.1080/19440049.2017.1336674
- Balayssac S, Danoun S, Gilard V, Martino R, Malet-Martino M. The POWER saga from 2007 to 2022: an example of a sexual enhancement dietary supplement tainted by different adulterants and still on the market. J Pharm Biomed Anal. 2023;227:115283. doi:10.1016/j.jpba.2023.115283
- Reeuwijk NM, Venhuis BJ, de Kaste D, Hoogenboom LA, Rietjens IM, Martena MJ. Sildenafil and analogous phosphodiesterase type 5 (PDE-5) inhibitors in herbal food supplements sampled on the Dutch market. Food Addit Contam Part a Chem Anal Control Expo Risk Assess. 2013;30(12):2027–2034. doi:10.1080/19440049.2013.848294
- Jairoun AA, Al-Hemyari SS, Shahwan M, Zyoud SH, Ibrahim B, Zyoud SH. Screening and determination of synthetic PDE-5 inhibitors in adulterated sexual enhancement supplements. Molecules. 2022;27(19):6737. doi:10.3390/molecules27196737
- Akuamoa F, Bovee TFH, van Dam R, et al. Identification of phosphodiesterase type-5 (PDE-5) inhibitors in herbal supplements using a tiered approach and associated consumer risk. Food Addit Contam Part a Chem Anal Control Expo Risk Assess. 2022;39(6):1021–1032. doi:10.1080/19440049.2022.2052972
- Li C, Xu D, Moezzi B. Identification of erectile dysfunction drugs in dietary supplements by liquid chromatography ion trap mass spectrometry. J Diet Suppl. 2021;18(3):261–277. doi:10.1080/19390211.2020.1758274
- Maresova V, Chadt J, Novakova E. Screening and semiquantitative analysis of drugs and drugs of abuse in human serum samples using gas chromatography-mass spectrometry. Neuro Endocrinol Lett. 2008;29(5):749–754.
- Tsuchihashi H. Automatic identification and semi-quantitative analysis of psychotropic drugs in serum using “GC/MS forensic toxicological database”. Shimadzu Technical Report. 2012;2012:1.
- Cohen PA, Maller G, DeSouza R, Neal-Kababick J. Presence of banned drugs in dietary supplements following FDA recalls. JAMA. 2014;312(16):1691–1693. doi:10.1001/jama.2014.10308
- Cohen PA. The FDA and adulterated supplements—dereliction of duty. JAMA Netw Open. 2018;1(6):e183329. doi:10.1001/jamanetworkopen.2018.3329
- Cohen PA, Wen A, Gerona R. Prohibited stimulants in dietary supplements after enforcement action by the US food and drug administration. JAMA Intern Med. 2018;178(12):1721–1723. doi:10.1001/jamainternmed.2018.4846
- Cohen PA, Bass S. Injecting safety into supplements - modernizing the dietary supplement Law. N Engl J Med. 2019;381(25):2387–2389. doi:10.1056/NEJMp1913004
- Denham BE. Dietary supplements in the USA: problematic trends. Public Health Nutr. 2021;24(9):2771–2775. doi:10.1017/S1368980021000665
- Nutrition Insight. Consumers inundated with adulterated and counterfeit supplements, flag global organizations; 2020. Available from: https://www.nutritioninsight.com/news/consumers-inundated-with-adulterated-and-counterfeit-supplements-flag-global-organizations.html. Accessed June 20, 2023.
- Natural Products Association. NPA Calls for FDA action on imported adulterated dietary supplement ingredients; 2020. Available from: https://www.npanational.org/news/npa-calls-for-fda-action-on-imported-adulterated-dietary-supplement-ingredients/. Accessed October 25, 2023.
- Conway K, Ferstl C, Kumar M. Dietary supplement adulteration - knowledge, attitudes, and practices of California health care professionals: a cross-sectional survey study. Patient Educ Couns. 2023;114:107824. doi:10.1016/j.pec.2023.107824
- U. S. Government accountability office report to congressional requesters. Dietary Supplements: FDA may have opportunities to expand its use of reported health problems to oversee products; 2013. Available from: http://www.gao.gov/assets/660/653113.pdf. Accessed October 25, 2023.
- Harel Z, Harel S, Wald R, Mamdani M, Bell CM. The frequency and characteristics of dietary supplement recalls in the United States. JAMA Intern Med. 2013;173(10):929–930. doi:10.1001/jamainternmed.2013.379
- Central District of California. Man sentenced to more than 8 years in prison for illegally importing, selling male sexual enhancement pills branded as “herbal” medicine. United States Department of Justice; 2019. https://www.justice.gov/usao-cdca/pr/man-sentenced-more-8-years-prison-illegally-importing-selling-male-sexual-enhancement. Accessed June 20, 2023.
- U. S. Food and Drug Administration. Former Springfield man sentenced for leading scheme to market dietary supplements; 2019. Available from: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/press-releases/march-11-2019-former-springfield-man-sentenced-leading-scheme-market-dietary-supplements. Accessed November 9, 2023.
- Ichim MC. The DNA-based authentication of commercial herbal products reveals their globally widespread adulteration. Front Pharmacol. 2019;10:1227. doi:10.3389/fphar.2019.01227
- Ziavrou KS, Noguera S, Boumba VA. Trends in counterfeit drugs and pharmaceuticals before and during COVID-19 pandemic. Forensic Sci Int. 2022;338:111382. doi:10.1016/j.forsciint.2022.111382
- U. S. Food and Drug Administration. Guilty plea in counterfeit viagra and cialis case. U.S. Department of Justice; 2014. Available from: http://wayback.archive-it.org/7993/20180126095342/https://www.fda.gov/ICECI/CriminalInvestigations/ucm381631.htm. Accessed October 25, 2023.
- U. S. Food and Drug Administration. Atlanta man convicted of illegally importing and distributing male enhancement products from China. U.S. Department of Justice; 2017. Available from: https://www.fda.gov/ICECI/CriminalInvestigations/ucm543784.htm. Accessed October 25, 2023.
- U. S. Food and Drug Administration. Two sentenced for trafficking in counterfeit Viagra and Cialis. U. S. Food and Drug Administration; 2016. Available from: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/press-releases/december-6-2016-two-sentenced-trafficking-counterfeit-viagra-and-cialis. Accessed October 25, 2023.
- U. S. Food and Drug Administration. Elk Grove man pleads guilty to importing counterfeit Viagra and Cialis from China; 2011. Available from: http://wayback.archive-it.org/7993/20180126095814/https://www.fda.gov/ICECI/CriminalInvestigations/ucm247707.htm. Accessed October 25, 2023.
- Campbell N, Clark JP, Stecher VJ, et al. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med. 2013;10(7):1842–1849. doi:10.1111/jsm.12172
- Eli Lilly and Company. Cialis® [package insert]; 2011. Available from: https://pi.lilly.com/us/cialis-pi.pdf. Accessed 6 November 2023.
- Pfizer Inc. Viagra® [package insert]; 2010. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/20895s039s042lbl.pdf. Accessed 6 November 2023.